These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 16092091)

  • 1. In vitro models of multiple system atrophy.
    Stefanova N; Reindl M; Poewe W; Wenning GK
    Mov Disord; 2005 Aug; 20 Suppl 12():S53-6. PubMed ID: 16092091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple system atrophy (MSA): topographic distribution of the alpha-synuclein-associated pathological changes.
    Armstrong RA; Cairns NJ; Lantos PL
    Parkinsonism Relat Disord; 2006 Sep; 12(6):356-62. PubMed ID: 16723266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of alpha-synuclein in the pathogenesis of multiple system atrophy.
    Wenning GK; Jellinger KA
    Acta Neuropathol; 2005 Feb; 109(2):129-40. PubMed ID: 15666181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.
    Orimo S; Uchihara T; Nakamura A; Mori F; Kakita A; Wakabayashi K; Takahashi H
    Brain; 2008 Mar; 131(Pt 3):642-50. PubMed ID: 18079166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoexpression of 14-3-3 proteins in glial cytoplasmic inclusions of multiple system atrophy.
    Komori T; Ishizawa K; Arai N; Hirose T; Mizutani T; Oda M
    Acta Neuropathol; 2003 Jul; 106(1):66-70. PubMed ID: 12669242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models of multiple system atrophy.
    Fernagut PO; Tison F
    Neuroscience; 2012 Jun; 211():77-82. PubMed ID: 21963351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-synuclein transgenic mice: relevance to multiple system atrophy.
    Fillon G; Kahle PJ
    Mov Disord; 2005 Aug; 20 Suppl 12():S64-6. PubMed ID: 16092093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grading of neuropathology in multiple system atrophy: proposal for a novel scale.
    Jellinger KA; Seppi K; Wenning GK
    Mov Disord; 2005 Aug; 20 Suppl 12():S29-36. PubMed ID: 16092088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau-positive glial cytoplasmic granules in multiple system atrophy.
    Nagaishi M; Yokoo H; Nakazato Y
    Neuropathology; 2011 Jun; 31(3):299-305. PubMed ID: 21062361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyses of copy number and mRNA expression level of the alpha-synuclein gene in multiple system atrophy.
    Jin H; Ishikawa K; Tsunemi T; Ishiguro T; Amino T; Mizusawa H
    J Med Dent Sci; 2008 Mar; 55(1):145-53. PubMed ID: 19845160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies.
    Refolo V; Bez F; Polissidis A; Kuzdas-Wood D; Sturm E; Kamaratou M; Poewe W; Stefanis L; Angela Cenci M; Romero-Ramos M; Wenning GK; Stefanova N
    Acta Neuropathol Commun; 2018 Jan; 6(1):2. PubMed ID: 29298733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-synuclein binding to rab3a in multiple system atrophy.
    Dalfó E; Ferrer I
    Neurosci Lett; 2005 May 20-27; 380(1-2):170-5. PubMed ID: 15854772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy.
    Sone M; Yoshida M; Hashizume Y; Hishikawa N; Sobue G
    Acta Neuropathol; 2005 Jul; 110(1):19-26. PubMed ID: 15895299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-synuclein pathology affecting Bergmann glia of the cerebellum in patients with alpha-synucleinopathies.
    Piao YS; Mori F; Hayashi S; Tanji K; Yoshimoto M; Kakita A; Wakabayashi K; Takahashi H
    Acta Neuropathol; 2003 Apr; 105(4):403-9. PubMed ID: 12624794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-synuclein immunoreactivity and ultrastructural study of glial cytoplasmic inclusions in multiple system atrophy.
    Wang Y; Lü C; Ye Z
    Chin Med J (Engl); 2002 Oct; 115(10):1491-5. PubMed ID: 12490094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of Hsc70 and Hsp70 in glial cytoplasmic inclusions in patients with multiple system atrophy.
    Kawamoto Y; Akiguchi I; Shirakashi Y; Honjo Y; Tomimoto H; Takahashi R; Budka H
    Brain Res; 2007 Mar; 1136(1):219-27. PubMed ID: 17240362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of neuronal degeneration of multiple system atrophy].
    Yoshida M; Sone M
    Brain Nerve; 2009 Sep; 61(9):1051-60. PubMed ID: 19803404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LRRK2 and parkin immunoreactivity in multiple system atrophy inclusions.
    Huang Y; Song YJ; Murphy K; Holton JL; Lashley T; Revesz T; Gai WP; Halliday GM
    Acta Neuropathol; 2008 Dec; 116(6):639-46. PubMed ID: 18936941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of alpha-synuclein immunoreactivity with inflammatory activity in multiple sclerosis lesions.
    Lu JQ; Fan Y; Mitha AP; Bell R; Metz L; Moore GR; Yong VW
    J Neuropathol Exp Neurol; 2009 Feb; 68(2):179-89. PubMed ID: 19151622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related motor dysfunction and neuropathology in a transgenic mouse model of multiple system atrophy.
    Fernagut PO; Meissner WG; Biran M; Fantin M; Bassil F; Franconi JM; Tison F
    Synapse; 2014 Mar; 68(3):98-106. PubMed ID: 24243499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.